Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.
- DOI
- 10.1080/10428194.2026.2721033
- Published
- 2026 Sep 13
- Container
- Leukemia & lymphoma
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10428194.2026.2721033,
title = {Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.},
author = {Schoenbeck K and Wei D and Hazra NC and Constantinescu C and Meng Y and Latremouille-Viau D and Marquez G and Yang D and Damon A and Sadek I and Guérin A and Clements J and DeMairo K and Hiller J and Flynn KE},
year = {2026},
journal = {Leukemia \& lymphoma},
doi = {10.1080/10428194.2026.2721033},
url = {https://doi.org/10.1080/10428194.2026.2721033}
}RIS
TY - JOUR TI - Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US. AU - Schoenbeck K AU - Wei D AU - Hazra NC AU - Constantinescu C AU - Meng Y AU - Latremouille-Viau D AU - Marquez G AU - Yang D AU - Damon A AU - Sadek I AU - Guérin A AU - Clements J AU - DeMairo K AU - Hiller J AU - Flynn KE PY - 2026 JO - Leukemia & lymphoma DO - 10.1080/10428194.2026.2721033 UR - https://doi.org/10.1080/10428194.2026.2721033 ER -
APA
K, S., D, W., NC, H., C, C., Y, M., D, L., G, M., D, Y., A, D., I, S., A, G., J, C., K, D., J, H., & KE, F. (2026). Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.. Leukemia & lymphoma. https://doi.org/10.1080/10428194.2026.2721033
Source records
- pubmed · retrieved 2026-09-26T12:35:35.294Z